Staccato Loxapine Pulmonary Safety in Patients With COPD

Clinical trial NCT00889837 · COMPLETED

Trial details

NCT number: NCT00889837
Sponsor: Alexza Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2009-06-01
Primary completion: 2009-08-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.